Gaganjit Kaur: Nesfatin-1 as a Neuroprotective Target in Hyperhomocysteinemia-Induced VCID
Gaganjit Kaur, Associate Professor at Maharaja Agrasen University, shared a post on LinkedIn, about a recent article by Gaganjit Kaur et al., published in International Journal of Drug Delivery Technology adding:
“L-Methionine 1.7 g/kg; for 8 weeks, orally, induced hyperhomocysteinemia, and consequent VCID.
Nesfatin-1 is a neuropeptide, highly expressed in brain.
Nesfatin-1 is involved in appetite regulation, mitochondrial biogenesis and energy production, neuroprotection.
In addition Nesfatin-1 exhibits potent anti-neuroinflammatory, antioxidant and antiapoptotic effect․”
Tiltle: Nesfatin-1 Ameliorated Cognitive Functions In L-Methionine-Induced Vascular Cognitive Impairment and Dementia By Restoring Brain Mitochondrial Activity
Authors: Gaganjit Kaur, Sushma Devi, Manish Shukla, Manish Kumar, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, Maharaja Agrasen School of Pharmacy, Maharaja Agrasen University, Baddi, Solan, Himachal Pradesh, India
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy